metformin has been researched along with Bisphosphonate Osteonecrosis in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhuang, J | 1 |
| Zu, J | 1 |
| Zhou, C | 1 |
| Sun, Y | 1 |
| Kong, P | 1 |
| Jing, Y | 1 |
| Nakagawa, T | 1 |
| Tsuka, S | 1 |
| Aonuma, F | 1 |
| Nodai, T | 1 |
| Munemasa, T | 1 |
| Tamura, A | 1 |
| Mukaibo, T | 1 |
| Kondo, Y | 1 |
| Masaki, C | 1 |
| Hosokawa, R | 1 |
| Glick, A | 1 |
| Sista, V | 1 |
| Johnson, C | 1 |
3 other studies available for metformin and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Bioinformatic Data Mining for Candidate Drugs Affecting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) in Cancer Patients.
Topics: Androgen Antagonists; Androgens; Aspirin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Caspas | 2022 |
Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Dipho | 2021 |
Oral Manifestations of Commonly Prescribed Drugs.
Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associ | 2020 |